Works matching IS 02683369 AND DT 2013 AND VI 48 AND IP 11

Results: 23

Outcomes of EAM conditioned autologous haematopoietic SCT for lymphoma. A matched pairs retrospective single-centre study analysis.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1486, doi. 10.1038/bmt.2013.90

By:

Loke, J;
Ward, J;
Mahendra, P;
Chaganti, S;
Malladi, R

Publication type:

Article

Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT).

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1389, doi. 10.1038/bmt.2013.68

By:

Tanaka, J;
Kanamori, H;
Nishiwaki, S;
Ohashi, K;
Taniguchi, S;
Eto, T;
Nakamae, H;
Minagawa, K;
Miyamura, K;
Sakamaki, H;
Morishima, Y;
Kato, K;
Suzuki, R;
Nishimoto, N;
Oba, K;
Masauzi, N

Publication type:

Article

Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1488, doi. 10.1038/bmt.2013.161

By:

Ustun, C;
Wiseman, A C;
DeFor, T E;
Yohe, S;
Linden, M A;
Oran, B;
Burke, M;
Warlick, E;
Miller, J S;
Weisdorf, D

Publication type:

Article

Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1395, doi. 10.1038/bmt.2013.73

By:

Auner, H W;
Szydlo, R;
van Biezen, A;
Iacobelli, S;
Gahrton, G;
Milpied, N;
Volin, L;
Janssen, J;
Nguyen Quoc, S;
Michallet, M;
Schoemans, H;
el Cheikh, J;
Petersen, E;
Guilhot, F;
Schönland, S;
Ahlberg, L;
Morris, C;
Garderet, L;
de Witte, T;
Kröger, N

Publication type:

Article

Duration of first remission, hematopoietic cell transplantation-specific comorbidity index and patient age predict survival of patients with AML transplanted in second CR.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1450, doi. 10.1038/bmt.2013.71

By:

Michelis, F V;
Atenafu, E G;
Gupta, V;
Kim, D D;
Kuruvilla, J;
Lambie, A;
Lipton, J H;
Loach, D;
Messner, H A

Publication type:

Article

Reduced-intensity conditioning followed by allogeneic transplantation in pediatric malignancies: a report from the Société Française des Cancers de l'Enfant and the Société Française de Greffe de Moelle et de Thérapie Cellulaire

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1401, doi. 10.1038/bmt.2013.82

By:

Paillard, C;
Rochette, E;
Lutz, P;
Bertrand, Y;
Michel, G;
Bordigoni, P;
Dalle, J H;
Rohrlich, P;
Vannier, J P;
Perel, Y;
Plantaz, D;
Leverger, G;
Sirvent, A;
Dore, E;
Isfan, F;
Merlin, E;
Pereira, B;
Halle, P;
Rabiau, N;
Kanold, J

Publication type:

Article

Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCT.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1472, doi. 10.1038/bmt.2013.87

By:

El-Cheikh, J;
Venton, G;
Crocchiolo, R;
Fürst, S;
Faucher, C;
Granata, A;
Oudin, C;
Coso, D;
Bouabdallah, R;
Vey, N;
Duran, S;
Fougereau, E;
Berger, P;
Chabannon, C;
Blaise, D

Publication type:

Article

Comorbidity burden in patients with chronic GVHD.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1429, doi. 10.1038/bmt.2013.70

By:

Wood, W A;
Chai, X;
Weisdorf, D;
Martin, P J;
Cutler, C;
Inamoto, Y;
Wolff, D;
Pavletic, S Z;
Pidala, J;
Palmer, J M;
Arora, M;
Arai, S;
Jagasia, M;
Storer, B;
Lee, S J;
Mitchell, S

Publication type:

Article

Reduced PTLD-related mortality in patients experiencing EBV infection following allo-SCT after the introduction of a protocol incorporating pre-emptive rituximab.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1465, doi. 10.1038/bmt.2013.84

By:

van der Velden, W J F M;
Mori, T;
Stevens, W B C;
de Haan, A F J;
Stelma, F F;
Blijlevens, N M A;
Donnelly, J P

Publication type:

Article

Incidence and risk factors for hypogammaglobulinemia in pediatric patients following allo-SCT.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1456, doi. 10.1038/bmt.2013.76

By:

Frangoul, H;
Min, E;
Wang, W;
Chandrasekhar, R;
Calder, C;
Evans, M;
Manes, B;
Bruce, K;
Brown, V;
Ho, R;
Domm, J

Publication type:

Article

Importance of factors influencing the decision to proceed with cord blood transplantation in adults: results of a web-based survey of the Canadian transplant community.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1482, doi. 10.1038/bmt.2013.85

By:

Chan, J Y S;
Tay, J;
Allan, D S

Publication type:

Article

Human herpes virus 6 reactivation: important predictor for poor outcome after myeloablative, but not non-myeloablative allo-SCT.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1460, doi. 10.1038/bmt.2013.78

By:

de Pagter, P J A;
Schuurman, R;
Keukens, L;
Schutten, M;
Cornelissen, J J;
van Baarle, D;
Fries, E;
Sanders, E A M;
Minnema, M C;
van der Holt, B R;
Meijer, E;
Boelens, J J

Publication type:

Article

Prospective qualitative and quantitative non-invasive evaluation of intestinal acute GVHD by contrast-enhanced ultrasound sonography.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1421, doi. 10.1038/bmt.2013.65

By:

Benedetti, E;
Bruno, B;
McDonald, G B;
Paolicchi, A;
Caracciolo, F;
Papineschi, F;
Pelosini, M;
Campani, D;
Galimberti, S;
Petrini, M

Publication type:

Article

Clinical evidence implicating gamma-delta T cells in EBV control following cord blood transplantation.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1478, doi. 10.1038/bmt.2013.75

By:

Farnault, L;
Gertner-Dardenne, J;
Gondois-Rey, F;
Michel, G;
Chambost, H;
Hirsch, I;
Olive, D

Publication type:

Article

The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1409, doi. 10.1038/bmt.2013.83

By:

Robinson, S P;
Canals, C;
Luang, J J;
Tilly, H;
Crawley, C;
Cahn, J Y;
Pohlreich, D;
Le Gouill, S;
Gilleece, M;
Milpied, N;
Attal, M;
Biron, P;
Maury, S;
Rambaldi, A;
Maertens, J;
Capria, S;
Colombat, P;
Montoto, S;
Sureda, A

Publication type:

Article

A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1437, doi. 10.1038/bmt.2013.79

By:

Locke, F;
Agarwal, R;
Kunnavakkam, R;
van Besien, K;
Larson, R A;
Odenike, O;
Godley, L A;
Liu, H;
Le Beau, M M;
Gurbuxani, S;
Thirman, M J;
Sipkins, D;
White, C;
Artz, A;
Stock, W

Publication type:

Article

Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1415, doi. 10.1038/bmt.2013.124

By:

Ustun, C;
Wiseman, A C;
DeFor, T E;
Yohe, S;
Linden, M A;
Oran, B;
Burke, M;
Warlick, E;
Miller, J S;
Weisdorf, D

Publication type:

Article

Cellular immunotherapy for plasma cell myeloma.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1377, doi. 10.1038/bmt.2013.54

By:

Garfall, A L;
Vogl, D T;
Weiss, B M;
Stadtmauer, E A

Publication type:

Article

Successful second autologous engraftment after long duration storage of hematopoietic stem cells.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1480, doi. 10.1038/bmt.2013.81

By:

Longoni, P;
Milanesi, M;
Di Nicola, M;
Devizzi, L;
Carrabba, M;
Arienti, F;
Ravagnani, F;
Tarella, C;
Montefusco, V;
Gianni, A;
Corradini, P;
Magni, M

Publication type:

Article

Allogeneic SCT for patients with high-risk peripheral T-cell lymphoma in first response.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1484, doi. 10.1038/bmt.2013.86

By:

Robles, M;
Vigouroux, S;
Tabrizi, R;
Bouabdallah, K;
Dilhuydy, M-S;
Parrens, M;
Leguay, T;
Pigneux, A;
Dumas, P-Y;
Lascaux, A;
Duclos, C;
Marit, G;
Milpied, N

Publication type:

Article

An update to the HLA Nomenclature Guidelines of the World Marrow Donor Association, 2012.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1387, doi. 10.1038/bmt.2013.93

By:

Bochtler, W;
Maiers, M;
Bakker, J N A;
Baier, D M;
Hofmann, J A;
Pingel, J;
Rist, H-G;
Oudshoorn, M;
Marsh, S G E;
Müller, C R;
Hurley, C K

Publication type:

Article

Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1444, doi. 10.1038/bmt.2013.80

By:

Sung, A D;
Grima, D T;
Bernard, L M;
Brown, S;
Carrum, G;
Holmberg, L;
Horwitz, M E;
Liesveld, J L;
Kanda, J;
McClune, B;
Shaughnessy, P;
Tricot, G J;
Chao, N J

Publication type:

Article

Allogeneic hematopoietic cell transplantation from alternative sources for adult Philadelphia chromosome-negative ALL: what should we choose when no HLA-matched related donor is available?

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 11, p. 1369, doi. 10.1038/bmt.2013.20

By:

Nishiwaki, S;
Atsuta, Y;
Tanaka, J

Publication type:

Article